NCT02159716
CART-meso in Mesothelin Expressing Cancers No drug interventions treatment 1 completed NCT04935359
Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2 treatment 3 completed NCT05558982
BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma treatment 2 recruiting NCT06608927
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma treatment 3 not_yet_recruiting NCT06445062
Study of RAS(ON) Inhibitors in Patients with Gastrointestinal Solid Tumors treatment 1 / 2 recruiting NCT06600906
Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT04005690
Targeted Pathway Inhibition in Patients With Pancreatic Cancer treatment 0 recruiting NCT02101021
Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma treatment 3 terminated NCT05685602
CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer treatment 1 suspended NCT04292743
Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma treatment 1 active_not_recruiting NCT04581343
A Phase 1B Study of Canakinumab, Spartalizumab, Nab-paclitaxel, and Gemcitabine in Metastatic PC Patients treatment 1 active_not_recruiting NCT06398587
Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma treatment 2 withdrawn NCT02583477
Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma treatment 1 / 2 completed NCT04631445
Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer No drug interventions treatment Not Available active_not_recruiting NCT04150042
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells treatment 1 recruiting NCT02600949
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer treatment 1 recruiting NCT04329949
Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma treatment 3 terminated NCT03450018
A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX treatment 1 / 2 terminated NCT04809766
Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma treatment 1 recruiting NCT05642962
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) treatment 1 / 2 recruiting NCT04666740
A Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy treatment 2 recruiting NCT03331640
A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy treatment 2 terminated NCT04888312
Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients treatment 1 / 2 active_not_recruiting NCT06168812
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer treatment 2 recruiting NCT02732938
Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients treatment 2 terminated NCT03610490
Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma treatment 2 terminated NCT05095064
Retrospective Study on the Efficacy and Tolerability of Liposomal Irinotecan Not Available Not Available unknown_status NCT02501902
Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC treatment 1 completed NCT04821284
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer treatment 1 / 2 recruiting NCT04523987
A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma. treatment 1 unknown_status NCT05039177
A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies treatment 1 / 2 active_not_recruiting NCT05630183
A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer treatment 2 recruiting NCT05737615
PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 No drug interventions diagnostic 1 recruiting NCT04990037
A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma treatment 1 completed NCT06390059
EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma treatment 2 recruiting NCT05472259
A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC) treatment 2 recruiting NCT04390763
Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) treatment 2 terminated NCT06206876
FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma No drug interventions treatment 1 not_yet_recruiting NCT04493060
Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer treatment 2 active_not_recruiting NCT02558894
Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma treatment 2 completed